Researchers studied a TAAR1 variant found in an Indian family with schizophrenia and showed that a single amino acid change ...

NDA submission supports the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home (outpatient) setting ...

Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality. Now-just over a year ...

Karuna Therapeutics and Bristol Myers Squibb are winners of the 2025 Gizmodo Science Fair for their research and development of Cobenfy (xanomeline-trospium), the first truly novel medication for ...

Andrew Miller is a driving force behind ­Cobenfy, which in 2024 became the first new kind of schizophrenia medication approved by the FDA in over 70 years. Rather than targeting the dopamine system, ...

If you or someone you love has been diagnosed with schizophrenia, you probably know how difficult it can be to find a treatment that truly works—and one that doesn't cause frustrating or even painful ...

The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, it remains underused – largely due to fears about serious side effects and ...

Treating schizophrenia with an older, cheaper drug, rather than with heavily promoted newer medications, reduces the cost by as much as 30 percent with no apparent difference in safety and ...